annual EBITDA:
-$204.15M-$11.99M(-6.24%)Summary
- As of today (August 29, 2025), ABCL annual EBITDA is -$204.15 million, with the most recent change of -$11.99 million (-6.24%) on December 31, 2024.
- During the last 3 years, ABCL annual EBITDA has fallen by -$443.30 million (-185.36%).
- ABCL annual EBITDA is now -178.47% below its all-time high of $260.17 million, reached on December 31, 2022.
Performance
ABCL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$42.53M+$13.53M(+24.14%)Summary
- As of today (August 29, 2025), ABCL quarterly EBITDA is -$42.53 million, with the most recent change of +$13.53 million (+24.14%) on June 1, 2025.
- Over the past year, ABCL quarterly EBITDA has increased by +$12.89 million (+23.26%).
- ABCL quarterly EBITDA is now -115.49% below its all-time high of $274.56 million, reached on March 31, 2022.
Performance
ABCL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$212.80M+$12.89M(+5.71%)Summary
- As of today (August 29, 2025), ABCL TTM EBITDA is -$212.80 million, with the most recent change of +$12.89 million (+5.71%) on June 1, 2025.
- Over the past year, ABCL TTM EBITDA has dropped by -$4.83 million (-2.32%).
- ABCL TTM EBITDA is now -147.80% below its all-time high of $445.22 million, reached on September 30, 2022.
Performance
ABCL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABCL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.2% | +23.3% | -2.3% |
| 3 y3 years | -185.4% | -1589.5% | -158.8% |
| 5 y5 years | -10000.0% | -3304.5% | -7618.9% |
ABCL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -178.5% | at low | -171.5% | +27.7% | -147.8% | +5.7% |
| 5 y | 5-year | -178.5% | at low | -115.5% | +27.7% | -147.8% | +5.7% |
| alltime | all time | -178.5% | at low | -115.5% | +27.7% | -147.8% | +5.7% |
ABCL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$42.53M(-24.1%) | -$212.80M(-5.7%) |
| Mar 2025 | - | -$56.05M(-4.8%) | -$225.69M(+3.6%) |
| Dec 2024 | -$204.15M(+6.2%) | -$58.85M(+6.3%) | -$217.77M(+0.9%) |
| Sep 2024 | - | -$55.37M(-0.1%) | -$215.86M(+3.8%) |
| Jun 2024 | - | -$55.42M(+15.1%) | -$207.97M(+5.7%) |
| Mar 2024 | - | -$48.13M(-15.5%) | -$196.69M(-4.7%) |
| Dec 2023 | -$192.16M(-173.9%) | -$56.94M(+19.9%) | -$206.31M(+21.2%) |
| Sep 2023 | - | -$47.48M(+7.6%) | -$170.23M(+169.1%) |
| Jun 2023 | - | -$44.13M(-23.6%) | -$63.25M(+288.9%) |
| Mar 2023 | - | -$57.75M(+176.8%) | -$16.27M(-105.1%) |
| Dec 2022 | $260.17M | -$20.86M(-135.1%) | $316.05M(-29.0%) |
| Sep 2022 | - | $59.50M(+1984.0%) | $445.22M(+23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $2.85M(-99.0%) | $361.83M(+0.6%) |
| Mar 2022 | - | $274.56M(+153.5%) | $359.77M(+34.6%) |
| Dec 2021 | $239.15M(+41.0%) | $108.31M(-553.4%) | $267.26M(-23.5%) |
| Sep 2021 | - | -$23.89M(-3116.4%) | $349.48M(-6.2%) |
| Jun 2021 | - | $792.00K(-99.6%) | $372.54M(+0.6%) |
| Mar 2021 | - | $182.05M(-4.4%) | $370.50M(+97.1%) |
| Dec 2020 | $169.62M(<-9900.0%) | $190.53M(<-9900.0%) | $188.00M(-5340.1%) |
| Sep 2020 | - | -$830.80K(-33.5%) | -$3.59M(+30.1%) |
| Jun 2020 | - | -$1.25M(+180.1%) | -$2.76M(+82.8%) |
| Mar 2020 | - | -$446.00K(-58.0%) | -$1.51M(+42.0%) |
| Dec 2019 | -$155.00K(-110.8%) | -$1.06M | -$1.06M |
| Dec 2018 | $1.44M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual EBITDA?
- What is the all time high annual EBITDA for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual EBITDA year-on-year change?
- What is AbCellera Biologics Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly EBITDA year-on-year change?
- What is AbCellera Biologics Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM EBITDA year-on-year change?
What is AbCellera Biologics Inc. annual EBITDA?
The current annual EBITDA of ABCL is -$204.15M
What is the all time high annual EBITDA for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual EBITDA is $260.17M
What is AbCellera Biologics Inc. annual EBITDA year-on-year change?
Over the past year, ABCL annual EBITDA has changed by -$11.99M (-6.24%)
What is AbCellera Biologics Inc. quarterly EBITDA?
The current quarterly EBITDA of ABCL is -$42.53M
What is the all time high quarterly EBITDA for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly EBITDA is $274.56M
What is AbCellera Biologics Inc. quarterly EBITDA year-on-year change?
Over the past year, ABCL quarterly EBITDA has changed by +$12.89M (+23.26%)
What is AbCellera Biologics Inc. TTM EBITDA?
The current TTM EBITDA of ABCL is -$212.80M
What is the all time high TTM EBITDA for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM EBITDA is $445.22M
What is AbCellera Biologics Inc. TTM EBITDA year-on-year change?
Over the past year, ABCL TTM EBITDA has changed by -$4.83M (-2.32%)